We are a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases.
Bristol Myers Squibb is led by our unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. We work every day to deliver innovative medicines for patients with serious and life-threatening diseases.
We’re committed to the UK. In 2020, our total economic footprint in the UK economy was an estimated £1bn in gross value added (GVA) and we supported 13,200 full time equivalent (FTE) jobs across the country1, with 95% of our procurement supplied from British businesses2.
Each day, the 1,200 people we directly employ in the UK work together for patients - it drives everything we do. In 2020, ~800,000 patients in the UK & Ireland relied on our medicines3. We are focused on helping millions of patients around the world in disease areas such as oncology, haematology, cardiology, immunology, fibrosis, and specialty medicines. We have built a sustainable pipeline through our Research & Development organisation, which invested £68 million in the UK in 2020. We seek out external partners to drive innovation and broaden and accelerate our work.
As global citizens, we work sustainably and responsibly and seek to give back. For example, in 2020, we donated £2 million to NHS cancer services, charities and patient groups to support NHS cancer services during the pandemic4.
Through the Bristol Myers Squibb Foundation, we promote health equity and strive to improve health outcomes of populations disproportionately affected by serious diseases and conditions, giving new hope to some of the world’s most vulnerable people.
Our Bristol Myers Squibb values and principles commit us to the highest standard of moral and ethical behaviour and affirms our conviction that "the priceless ingredient of every medicine is the honour and integrity of its maker."
Our workforce is globally diverse to create an inclusive, high-performance culture that is agile, entrepreneurial, and accountable.
The Bristol Myers Squibb Foundation promotes health equity and seeks to improve the health outcomes of populations disproportionately affected by serious diseases. The Bristol Myers Squibb Foundation has a number of Global Initiatives & Programmes.
Our company is guided by a Leadership Team that brings a rich and diverse set of experience to navigate an evolving and fast-paced global healthcare landscape. We are pledged to deliver on our commitments to our patients and customers, to our employees, to our global communities, to our shareholders, and to our environment. Ultimately, our success will be measured by the difference we can make in the lives of patients. The Leadership Team is responsible for the day-to-day operation of the company.
1 BMS internal data
2 BMS internal data
3 BMS internal data
4 Standing United (2020). Bristol Myers Squibb: Delivering Care and Support to Communities Across the UK Accessed Feb 2022
Date of preparation: March 2023